2nd Annual International naltrexone low dose Awareness week 18 to October 24, 2010
Devon, PA (Business Wire) 30 September 2010
United Kingdom.
naltrexone was approved by the Food and Drug Administration (FDA) approved since 1985 for alcoholism and drug addiction treatment, but at a much lower dose, it was a safe and effective treatment for MS and found other autoimmune diseases such as rheumatoid arthritis, fibromyalgia, Lupus and Crohn’s? Crohn’s NDA has even been found effective in fighting certain cancers. Unfortunately, all neurologists and doctors willing to prescribe LDN as it is a new off-label use of generic drugs at low cost.
More than 100,000 people worldwide are currently LDN, the majority in the U.S., where the drug is easily made by mixing the drug with a doctora? Recipe. NDA has been reported by patients and their doctors to end MS and is more effective if the time of diagnosis of the disease taken early – before a permanent disability occurred. MS current immunosuppressive therapies require painful injections every day or every week can have toxic side effects, cost more than 000 € per month, and were only found in 30-35% effective two years studying in slowing the progression of the disease clinics.
LDN costs about for months? s is offering a capsule orally before bed at night, is nontoxic and reported on two surveys of users and numerous witnesses to 70-80% effectively prevents multiple sclerosis disease progression. NDA could save billions of dollars in drug costs.
United Kingdom, where expensive MS drugs are not covered by private health insurance, was quickly recognized NDA by the medical community and charity as a treatment for MS MS.
United States, the National Multiple Sclerosis Society (NMSS) to date, a study at Penn State Medical LDNA financed? Using mice with a disease similar to MS, the results of tens of thousands of people after taking LDN â have reported confirmed? MS stopped their empire.
A new study scheduled NDA-backed www.CureTogether.com transparency and Life Sciences (www.TransparencyLS.com) is a new method for the development of drugs for better use of open source to prove the effectiveness of NDA and awareness in the medical community .
For further information on the NDA for the treatment of MS and other autoimmune diseases, visit www.LDNaware.org the bridge in the world of NDA information, resources and events.
# # #
clear = “all”
Gateway Credit Card